Pharmacists in Lone Tree, Colorado


28 Pharmacists found in Lone Tree
male pharmacist

Jeffrey Saba Moon, PHARM.D


Pharmacist
7817 Park Meadows Dr, Lone Tree, CO 80124
303-799-3905    

female pharmacist

Katherine Joan Carnett, PHARMD


Pharmacist
9229 Lincoln Avenue, Lone Tree, CO 80124
303-649-9749    

female pharmacist

Laura Zimmerly, RPH


Pharmacist
10103 Ridgegate Pkwy Ste 117, Lone Tree, CO 80124
303-729-2719     303-792-2728



female pharmacist

Laura Phillips, PHARMD, BCCCP



10101 Ridgegate Pkwy, Lone Tree, CO 80124
720-225-1160     720-225-1160

female pharmacist

Lora Kayali, RPH


Pharmacist
9229 E Lincoln Ave, Lone Tree, CO 80124
303-649-9749    

female pharmacist

Maria Kamci, RPH


Pharmacist
8686 Park Meadows Center Dr, Lone Tree, CO 80124
303-708-8571    

female pharmacist

Maria Cristina Buhay, PHARM.D.


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
10101 Ridgegate Pkwy, Lone Tree, CO 80124
303-225-1100    

female pharmacist

Melanie Carpenter


Pharmacist
10101 Ridgegate Pkwy, Lone Tree, CO 80124
720-225-1507    

male pharmacist

Mr. Scott Grierson Wheeldon, PHARMACIST


Pharmacist
8267 Sweet Water Rd, Lone Tree, CO 80124
303-792-3929     303-792-5152

male pharmacist

Mr. Scott Alan Eskanos, R.PH.


Pharmacist
10103 Ridgegate Pkwy, Suite 117a, Lone Tree, CO 80124
303-468-0300     303-468-0307

female pharmacist

Shari Sue Walls, RPH


Pharmacist
10103 Ridgegate Pkwy, Lone Tree, CO 80124
303-729-2719     303-792-2728

male pharmacist

Steve Rohleder, PHARMD


Pharmacist
9229 E Lincoln Ave, Safeway Pharmacy #1548, Lone Tree, CO 80124
303-649-9749     303-649-9148


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.